SC 13G: Upstream Bio, Inc.
Ticker: UPB · Form: SC 13G · Filed: Oct 18, 2024 · CIK: 2022626
| Field | Detail |
|---|---|
| Company | Upstream Bio, Inc. (UPB) |
| Form Type | SC 13G |
| Filed Date | Oct 18, 2024 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sc-13g
AI Summary
SC 13G filing by Upstream Bio, Inc..
Risk Assessment
Risk Level: low
FAQ
What type of filing is this?
This is a SC 13G filing submitted by Upstream Bio, Inc. (ticker: UPB) to the SEC on Oct 18, 2024.
What is the risk level of this SC 13G filing?
This filing has been assessed as low risk.
What are the key financial figures in this filing?
Key dollar amounts include: $0.001 (INC. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class).
How long is this filing?
Upstream Bio, Inc.'s SC 13G filing is 4 pages with approximately 1,307 words. Estimated reading time is 5 minutes.
Where can I view the full SC 13G filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 1,307 words · 5 min read · ~4 pages · Grade level 10.2 · Accepted 2024-10-18 18:10:56
Key Financial Figures
- $0.001 — INC. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class
Filing Documents
- d814421dsc13g.htm (SC 13G) — 48KB
- 0001193125-24-239740.txt ( ) — 49KB
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information in this statement is true, complete and correct. Dated: October 18, 2024 BCLS Fund III Investments, LP By: BCLS Fund III Investments GP, LLC, its general partner By: Bain Capital Life Sciences Fund III, L.P., its member By: Bain Capital Life Sciences III General Partner, LLC, its general partner By: Bain Capital Life Sciences Investors, LLC, its manager By: /s/ Ricky Sun Name: Ricky Sun Title: Partner